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In chronic renal disease, the progressive accumulation of
collagen and other extracellular matrix proteins in the
mesangium results in fibrosis, glomerulosclerosis, and
eventual renal failure. Mice deficient in proa2(I) collagen are
not only a model of osteogenesis imperfecta but also
accumulate fibrillar homotrimeric type I collagen in the
mesangium. This accumulation spreads to the subendothelial
space in the peripheral capillary loops. Picosirius red staining
of kidney sections demonstrates that in comparison to
wild-type mice, Col1a2-deficient homozygous and
heterozygous mice exhibit abnormal glomerular collagen
deposition in a gene dosage-dependent manner. The
glomerulopathy initiates during the first postnatal week,
appears progressive following the pattern of glomerular
maturation and results in albuminuria in severely affected
animals. In situ hybridization revealed no gross differences in
steady-state proa1(I) and proa2(I) collagen mRNA levels
among the three genotypes. Quantitative reverse
transcriptase-polymerase chain reaction, however, using
whole kidney sections showed a twofold increase in
steady-state proa1(I) collagen mRNA in 1-month
homozygous Col1a2-deficient animals compared with
wild-type and heterozygous animals. We suggest that
glomerular collagen deposition seen in the osteogenesis
imperfecta model mice is, in part, owing to pretranslational
mechanisms and may represent an over compensation of
wound healing.
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A novel type I collagen glomerulopathy was identified in the
Col1a2-deficient mouse model, characterized by the deposi-
tion of homotrimeric type I collagen in the renal mesan-
gium.1 Under normal physiologic conditions, very little type I
collagen is in the glomerulus.2,3 In chronic renal disease,
progressive accumulation of collagen and other extracellular
matrix (ECM) components in the mesangium results in
fibrosis, glomerulosclerosis, and renal failure.4–6 The primary
event leading to development of the glomerulopathy in
Col1a2-deficient mice appears to be deposition of homo-
trimeric type I collagen in the mesangial matrix, similar to
the progressive glomerular decline following injury and may
represent overcompensation of the glomerular wound
healing response.7–9 To characterize further the type I
collagen glomerulopathy, we defined the pattern of disease
initiation and progression, and began investigating the
mechanisms responsible for glomerular collagen deposition
in Col1a2-deficient mice.
The predominant isotype of type I collagen is a
heterotrimer composed of two proa1(I) collagen chains and
one similar, but genetically distinct, proa2(I) collagen chain
[a1(I)2a2(I)].
10,11 The homotrimeric type I collagen isotype
containing three proa1(I) collagen chains, [a1(I)3] is a minor
isotype, whose role is not well understood.10,11 Homotrimer
is found embryonically2,12 in small amounts in skin,13 in
certain tumors and cultured cancer cell lines,12,14,15 and also
during wound healing.7 Cultured mesangial cells produce
homotrimeric type I collagen, further suggesting that
homotrimer plays a role in wound healing.7,8
The Col1a2-deficient mouse model, otherwise known as
the oim mouse (osteogenesis imperfecta model) is homo-
zygous for a spontaneous nucleotide deletion in the Col1a2
gene, resulting in a frameshift altering the carboxy–propep-
tide of the proa2(I) collagen chain. Although the carboxy
–propeptide is not present in mature type I collagen, it is
responsible for association of the a2(I) chain with the a1(I)
chains during assembly of the triple helix.16–18
The glomerulus, a network of capillaries, serves as the
filtration unit of the kidney, with mesangial cells composing
30–40% of the cell population, functioning to create and
integrate a structural scaffold for the capillary network.2,8
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Mesangial cells secrete ECM proteins to provide a framework
for the scaffold. Glomeruli form in a centrifugal pattern
around the renal medulla. At birth, mouse kidneys have
numerous glomeruli, yet only a fraction are functional.
Between birth and 21 days of age, glomeruli gain function
regionally,19 with initial functioning glomeruli in the
juxtamedullary region of the deep cortex.20,21 As the mouse
develops, there is stepwise induction of new nephrons and
glomeruli gain functional activity, progressing until full
maturation when glomeruli in the outer cortex assume the
majority of glomerular function.20–22 A similar progression of
glomerular maturation occurs in other mammalian species,
including humans.21,23,24
Several studies using animal models demonstrate that
glomerular collagen deposition can result from either
increased pretranslational expression of type I collagen
(transcriptional upregulation) or decreased matrix metallo-
proteinase (MMPs) expression and/or activity, or both.25–31
In this study, we sought to determine whether the collagen
glomerulopathy in the Col1a2-deficient model was progres-
sive with pre- or postnatal initiation and whether pretransla-
tional upregulation of type I collagen expression was involved
in glomerular collagen deposition. Through histologic
examination, urine analyses, and quantitative reverse
transcriptase-polymerase chain reaction (RT-PCR), we
determined that the type I collagen glomerulopathy in
Col1a2-deficient mice initiates postnatally, progresses with
age and glomerular maturation, is associated with a gene
dose effect, impairs renal function, and is, in part, owing to
increased steady-state proa1(I) collagen mRNA levels.
RESULTS
Heterozygous mice demonstrate collagen glomerulopathy
Picrosirius red-stained sections of Col1a2-deficient, hetero-
zygous, and wild-type mice were examined by light
microscopy to determine lesion score. Heterozygous mice
exhibited collagen deposition in their glomeruli characteristic
of the type I collagen glomerulopathy identified in the
Col1a2-deficient mice, though their lesions were less severe
(Figure 1).
Glomerulopathy initiation
We determined the lesion score of heterozygous and Col1a2-
deficient mouse kidneys at 1 day, 1 week, 2 weeks, and
1 month of age to determine whether initiation of glomerular
fibrillar collagen deposition occurred postnatally. Figure 2
highlights the postnatal initiation of collagen deposition
within the renal glomeruli. Glomeruli of 1-day-old mice lack
fibrillar collagen deposition across all genotypes. However, by
1 week of age, fibrillar collagen deposition was present in
Col1a2-deficient and heterozygous mice. By 1 month of age,
Col1a2-deficient mice exhibited lesions that ranged from
mild to severe, whereas heterozygous mice had mild to
moderate lesions. Interestingly, the younger Col1a2-deficient
mice had glomerular collagen deposition in the juxtamedul-
lary region in contrast to older mice, where lesions were
throughout the cortex.
Morphometry
To investigate further disease progression, we developed a
morphometry-mapping system to examine severity and
localization of individual lesions. Morphometric analyses
(Figure 3, Supplementary Material) confirmed that the type I
collagen glomerulopathy is progressive and exhibits a gene
dose effect. At 2 weeks of age, 55% of Col1a2-deficient
glomeruli were affected, which increased to 95% by 1 month
of age. In comparison, only 8% of heterozygous glomeruli
were affected at 2 weeks of age increasing to 53% by 1 month.
Polynomial orthogonal contrast analysis of the morpho-
metric data confirmed a linear gene dose response.
Differences also existed in lesion severity and percent of
glomeruli affected between the cortical and juxtamedullary
regions within individual kidneys. The morphometry score in
the juxtamedullary region was significantly greater than the
cortical region in Col1a2-deficient mice at 2 weeks and
1 month of age (Figure 4a). The mean juxtamedullary
morphometry score in 2-week Col1a2-deficient animals was
0.94, whereas the 1-month juxtamedullary morphometry
score was 2.1, demonstrating disease progression. Similar
findings were true of percent glomeruli affected (Figure 4b).
At 2 weeks of age, 73% of juxtamedullary glomeruli were
affected as compared with 36% of cortical glomeruli in
Col1a2-deficient mice. In contrast, by 1 month of age 97% of
juxtamedullary and 93% of cortical glomeruli were affected.
A similar pattern exists in heterozygous mice, though the
shift in affected glomeruli from predominantly juxtamedul-
lary to both juxtamedullary and cortical involvement was not
as dramatic. These data suggest a centrifugal pattern of
a b c
Figure 1 | Deposition of type I collagen in heterozygous and Col1a2-deficient glomeruli. Picrosirius red-stained sections of (a) wild-type
(lesion score 0), (b) heterozygous (lesion score 1), and (c) Col1a2-deficient (lesion score 4) kidneys from 1-month-old mice. Arrows indicate
glomeruli. Asterisks denote affected (Picrosirius redþ ) glomeruli.
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glomerular collagen deposition as the animal ages, with
disease initiation occurring primarily in the juxtamedullary
region and progressing to involve both the juxtamedullary
and cortical regions of the kidney. Lesion development
coincides with glomerular maturation, which progresses
from the juxtamedullary region outward toward the
cortex.19–21 These data taken together confirm that initiation
of the type I collagen glomerulopathy occurs postnatally
before 1 week of age and that initiation of disease coincides
with the maturation of glomeruli into functional filtration
units.22
Subendothelial type I collagen accumulation
Ultrastructural examination of glomerular collagen deposi-
tion in wild-type and severely affected Col1a2-deficient
(lesion score G4) kidney sections revealed that the fibrillar
collagen was extracellular, accumulating in the mesangial
matrix as well as between the fenestrated endothelial cells and
the glomerular basement membrane within the glomeruli
(Figure 5). In addition, there was podocyte foot process
effacement in areas demonstrating severe fibrillar collagen
deposition and marked separation of endothelial cells from
the basement membrane. However, in all sections, the
glomerular basement membrane remained intact.
Albuminuria
Analysis of albumin excretion in urine of wild-type and
Col1a2-deficient mice demonstrated significant increases in
albumin excretion in Col1a2-deficient mice (Table 1).
Col1a2-deficient mice had a mean albumin/creatinine ratio
of 38.19 mg albumin/mg creatinine, whereas wild-type had a
mean ratio of 0.499 mg albumin/mg creatinine. Mice with
higher lesion scores had greater albuminuria than those with
less severe lesion scores. These data suggest that increasing
deposition of homotrimeric collagen into the glomeruli
results in impaired renal function.
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Figure 2 | Initiation of type I collagen deposition in glomeruli occurs postnatally. Picrosirius red stain of (a, d, and g) 1-day-old, (b, e, and h)
2-week-old, and (c, f, and i) 1-month-old mice. (a–c) Wild-type (þ /þ ) mice do not demonstrate collagen deposition and have lesion
scores of 0. (d–f) Heterozygous (þ /) mice show evidence of disease at 2 weeks (inset: enlargement of indicated glomeruli (e)), demonstrating
lesion scores of 0 at 1 day, 1 at 2 weeks, and 1 at 1 month. (g–i) Col1a2-deficient (/) mice also show evidence of deposition at 2 weeks
with a lesion score of 0 at 1 day, 1 at 2 weeks, and 4 at 1 month. Arrows indicate glomeruli. Asterisks denote affected (Picrosirius redþ )
glomeruli.
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Figure 3 | The type I collagen glomerulopathy in heterozygous
mice demonstrate a gene dose effect (*Po0.0001) that is
progressive with age (**Po0.0001). The percent of affected
glomeruli per field is significantly greater in Col1a2-deficient (/)
than heterozygous (þ /) kidneys at both 2 weeks and 1 month of
age. Significant differences in the percent of glomeruli affected
between kidneys examined at 2 weeks and 1 month of age is also
shown irregardless of genotype.
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Steady-state proa1(I) and proa2(I) collagen mRNA
In situ hybridization with Col1a1 and Col1a2 antisense probes
to wild-type and Col1a2-deficient mouse kidneys demons-
trated no differences in temporal or spatial distribution of
Col1a1 and Col1a2 mRNAs (Supplementary Material). To
assess quantitatively whether type I collagen deposition in the
glomerulus of Col1a2-deficient mice is associated with
increased steady-state proa1(I) and proa2(I) collagen mRNA
levels, we evaluated Col1a2-deficient, heterozygous and wild-
type mice at 1 week, 2 weeks, and 1 month of age by
quantitative RT-PCR (Figure 6). A significant increase in
steady-state proa1(I) collagen mRNA levels was seen in
1-month old Col1a2-deficient mice as compared with age-
matched heterozygous and wild-type animals. In contrast, a
significant difference in steady-state proa2(I) collagen mRNA
was not seen. Figure 6 also demonstrates a significant
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Figure 4 | The type I collagen glomerulopathy initiates postnatally and glomeruli sequentially become affected in a centrifugal pattern
from the juxtamedullary (jm) to the cortical (c) region in a distribution consistent with glomerular maturation and initiation of
function. (a) Demonstrates that there is a significant difference between the morphometry score in jm and c glomeruli at 2 weeks and 1 month
of age in Col1a2-deficient mice with more severely affected glomeruli located in the jm region where glomerular function initiates.
(b) Demonstrates a significant difference between percent of glomeruli affected per field between jm and c glomeruli in Col1a2-deficient mice
at 2 weeks of age whereas greater than 90% of jm and c glomeruli per field are affected by 1 month of age. Conversely, the heterozygous
animals lack a significant difference at the earlier time point but demonstrate a significant difference in both lesion severity and percent
glomeruli affected per field between jm and c glomeruli at 1 month of age. Further, the lesion severity and percent glomeruli affected is
significantly different between the 2 week and 1 month ages (y), confirming the progressive nature of the glomerulopathy (*Po0.05,
**Po0.005, ***Po0.0001).
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Figure 5 | (a) Electron microscopy of glomeruli from wild-type and (b and c) Col1a2-deficient mice (lesion score 4) demonstrate that the
Col1a2-deficient glomeruli exhibit deposition of extracellular fibrillar type I collagen (c) into the subendothelial space displacing
the fenestrated endothelium (e) from the underlying glomerular basement membrane (b). Fibrils demonstrating cross striation of
organized collagen (b; inset) were also present. In areas of severe collagen deposition and expansion of the subendothelial space, podocyte
(p) foot process effacement is seen (c). It is hypothesized that the type I collagen is being produced by the mesangial (m) cell followed
by deposition in the subendothelial space. In all mice examined, the glomerular basement membrane (GBM) was intact. Wild-type provided for
comparison (a).
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decrease in proa1(I) and proa2(I) collagen mRNA with
increasing age across all three genotypes.
DISCUSSION
The original characterization of the type I collagen glomer-
ulopathy in Col1a2-deficient mice demonstrated, by immuno-
histochemistry, that the fibrillar material deposited in the
glomerulus was type I collagen and suggested that hetero-
zygous mice did not exhibit glomerular collagen deposition.1
However, revision of the lesion scoring system to include the
examination of kidney sections stained with Picrosirius red
revealed that heterozygous mice indeed accumulate glomer-
ular fibrillar collagen, though to a lesser degree. Heterozygous
mice, like Col1a2-deficient mice, exhibit a range of lesion
scores, though the age-dependent increase was less severe,
suggesting that the loss of proa2(I) collagen or the presence of
homotrimeric type I collagen has a gene dosage effect. It is not
an uncommon phenomenon for heterozygous animals to be
less severely affected than their homozygous counterparts and
has been shown to occur in several disorders including
achondroplasia.32,33
We also showed that the deposition of type I collagen
initiates postnatally, before 1 week of age, and that the
progression follows a pattern similar to glomerular matura-
tion. Initially, within 1 week of life, affected glomeruli were
confined to the juxtamedullary region. However, by 1 month
of age, affected glomeruli were evident throughout the
juxtamedullary and cortical regions in Col1a2-deficient mice,
following the pattern for functional maturation of glomeruli,
which is complete by 21 days of age.19 The glomerulopathy
progressed in a centrifugal pattern, coinciding with initiation
of glomerular function and maturation.20,21 Further, as
Col1a2-deficient mice age, increasing amounts of fibrillar
collagen were deposited resulting in pathological conse-
quences; Col1a2-deficient mice exhibit microalbuminuria
and mice with greater lesion scores have a higher degree of
microalbuminuria. With age, Col1a2-deficient mice demons-
trate increasing severity in glomerular lesions and functional
impairment of their kidneys, consistent with glomerular
injury.
Ultrastructural analyses of Col1a2-deficient kidneys de-
monstrated fibrillar collagen deposition in the subendothelial
space between the fenestrated endothelium and the basement
membrane, though basement membrane appeared normal.
Regions of severe deposition exhibited podocyte foot process
effacement. Podocytes function in ultrafiltration and estab-
lishment of the glomerular barrier to protein. Foot process
effacement and overall decrease in podocyte number has been
shown to result in increased proteinuria, a hallmark of
glomerular injury.34,35 Similar findings were seen in a mouse
model of glomerulosclerosis in which the transforming
growth factor (TGF)-b1 transgene under the control of a
murine albumin promoter expressed high plasma TGF-b1
levels as well as a subendothelial type I collagen accumulation
in the glomeruli and proteinuria in the severely affected
mice.36,37 We hypothesize that the deposition of type I
collagen in the mesangial matrix and the subendothelial space
results in impaired podocyte/endothelial cell interactions,
podocyte foot process effacement, increased proteinuria, and
is responsible for the progressive glomerular functional
decline.38
In situ hybridization analyses of Col1a2-deficient, hetero-
zygous, and wild-type kidneys demonstrated no temporal or
Table 1 | Col1a2-deficient mice demonstrate albuminuria as
compared with wild-type animals
Genotype n Albumin (lg)/creatinine (mg) (range)
Wild-type 12 0.5070.14 (0.06–1.43)
Col1a2-deficient 14 38.19712.33* (0.41–128.55)
Lesion score
0 12 0.5070.14
1 1 0.41
2 4 8.9176.53**
3 6 42.27720.63*
4 3 81.65725.15*
*Po0.0001.
**Po0.005.
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Figure 6 | Quantitative RT-PCR demonstrates a significant
increase in (a) proa1(I) collagen mRNA expression in 1 month
Col1a2-deficient (/) animals when compared with
age-matched heterozygous (þ /) and wild-type (þ /þ )
animals (*Po0.05). It also demonstrates a decrease in proa(I)
collagen mRNA expression with age independent of genotype
(**Po0.01) and a significant difference in (b) proa2(I) collagen mRNA
expression when comparing 1 month and 1 week animals for all
three genotypes.
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spatial differences in proa1(I) and proa2(I) collagen steady-
state mRNA levels. However, subsequent quantitative RT-
PCR was performed due to insensitivity of in situ hybridiza-
tion to quantitative changes and demonstrated a significant
increase in proa1(I) collagen mRNA in 1-month Col1a2-
deficient animals, as compared with age-matched hetero-
zygous and wild-type animals.
The presence of increased steady-state proa1(I) and
proa2(I) collagen mRNA levels normally at early ages may
be due to developmental changes and thus mask any
differences that might be occurring due to initiation of the
glomerulopathy. Furthermore, the quantitative RT-PCR
analysis was performed on whole kidney sections, and to
clarify whether proa1(I) and proa2(I) collagen steady-state
mRNA increases occur with initiation of disease, quantitative
RT-PCR analyses needs to be performed on isolated
glomeruli.
Under normal physiologic conditions, a balance exists
between synthesis and degradation of type I collagen and
other ECM components. To maintain homeostasis, synthesis
and degradation must remain balanced. However, in disease
states, the balance is often disrupted resulting in increased
synthesis and/or decreased degradation, and thus, accumula-
tion of ECM components.39 Steady-state levels of proa1(I)
collagen mRNA were increased by twofold in 1-month-old
Col1a2-deficient animals relative to age-matched heterozy-
gous and wild-type animals, suggesting that the aberrant
accumulation is due, at least in part, to a pretranslational
increase in type I collagen gene expression.
Type I collagen degradation is regulated by MMPs and
their associated tissue inhibitor of metalloproteinases
(TIMPs). In a rat model of proliferative glomerulonephritis
glomerular type I and IV collagen deposition is associated
with decreased MMP-9 steady-state mRNA expression with-
out differences in expression of TIMP-1, MMP-2, MMP-13,
MT1-MMP, type I collagen, or type IV collagen steady-state
mRNA.30 This contrasts the ICR-derived glomerulonephritis
mice (ICGN) mouse model of idiopathic nephritic syndrome
that demonstrates proteinuria, hypoproteinemia, and hyper-
lipidemia as well as type I collagen deposition in their
glomeruli.28,29,31 ICGN mice have decreased MMP-1, 2, and 9
activity28 with a corresponding decrease in MMP-2, MMP-9,
MT1-MMP, TIMP-1, and TIMP-2 protein.29 Subsequent
studies of ICGN mice also demonstrate increased steady-state
proa1(I) collagen and proa1(III) collagen mRNA levels
relative to control animals.31 Therefore, deposition of ECM
components in the ICGN mouse result from increased
pretranslational synthesis as well as decreased degradative
capacity of renal MMPs. The TGF-b transgenic mice also
demonstrate glomerular type I collagen deposition associated
with increased steady-state a1(I) mRNA levels in young mice
and increased activity of MMP-2 and TIMP-1 in severely
affected animals indicating that in the presence of elevated
TGF-b, glomerular collagen deposition is the result of an
imbalance in pretranslational synthesis and degradative
capacities mediated by MMP/TIMP interactions.25 Despite
increased proa1(I) collagen mRNA levels, we cannot rule out
that decreased MMP enzyme expression and/or activity may
contribute to the glomerular type I collagen accumulation in
Col1a2-deficient animals. Particularly, as 1-month hetero-
zygous animals also demonstrate glomerular deposition
without a significant increase in collagen gene expression as
measured by quantitative RT-PCR.
Our findings are also consistent with the concept that the
glomerular collagen deposition seen in the Col1a2-deficient
mice may represent overcompensation of the glomerular
wound healing response. Wild-type rat mesangial cells when
subjected to tissue culture produce type I collagen of which
more than 50% is homotrimeric. We postulate that the type I
collagen accumulation in Col1a2-deficient mice reflects an
injury response to the initiation of increased glomerular
capillary pressures that occurs with glomerular maturation
(functional activation). Increased glomerular capillary pres-
sure is known to be tightly associated with increased ECM
production, mesangial expansion, and progression of glo-
merulosclerosis.40,41 Moreover, we previously demonstrated
that Col1a2-deficient mice have reduced biomechanical
integrity of the aorta.42,43 If the glomerular capillaries have
similar decreased vascular integrity then functional activation
of the glomeruli may induce the wound response owing to
altered mechanical strain on the capillaries. Though TGF-b,
connective tissue growth factor, and the phosphatidylinositol
3’ kinase/Akt-signaling pathway are implicated in cellu-
lar sensing of mechanical strain in mesangial cells, whether
these factors or even mechanical strain plays a role in
homotrimeric type I collagen deposition remains to be
elucidated.41,44
In summary, we demonstrated that the type I collagen
glomerulopathy affects heterozygous animals in a dose–
response manner, initiates postnatally following a pattern of
glomerular maturation, and is progressive resulting in
impaired renal function. We also suggest mechanistically that
the glomerulopathy is due, in part, to pretranslational up-
regulation of proa1(I) collagen mRNA expression and suggests
that further investigation is needed to determine in vivo
expression and activity of MMPs in Col1a2-deficient mice.
MATERIALS AND METHODS
Animals
Homozygous B6C3Fe a/a- Col1a2oim/J (Col1a2-deficient, /);
heterozygous (/þ ) and wild-type (þ /þ ) mice were purchased
from Jackson Laboratory (Bar Harbor, ME). Animals were housed
in an AAALAC accredited animal facility, provided with water and
food (Purina 5008 Formulab Diet; Purina Mills Inc., Richmond, IN)
ad libitum, and cared for in accordance with an approved University
of Missouri Animal Care and Use protocol. þ /þ , þ /, and /
genotypes were determined by PCR-restriction fragment-length
polymorphism analysis.45
Animals were divided into four age groups, 1 month (n¼ 52
mice), 2 weeks (n¼ 56), 1 week (n¼ 55), and 1 day (n¼ 26) of age.
Animals were killed and kidneys were harvested. The right kidney
was snap-frozen in liquid nitrogen and stored at 801C. The left
kidney was fixed in 10% neutral-buffered formalin for 48 h.
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Microscopy
Formalin-fixed kidneys embedded in paraffin were sectioned
longitudinally (5mm) and stained with Picrosirius red stain.
Glomeruli within individual sections were examined in a blinded
fashion and a glomerular lesion score for each individual kidney was
determined. Glomerular lesion scores were determined using the
following scale: G1 – mild lesions;p50% of glomeruli affected; G2 –
moderate lesions; p50% of glomeruli affected; G3 – moderate
lesions; X50% glomeruli affected; G4 – severe lesions; X50% of
glomeruli affected. A positive correlation was demonstrated between
the amount of collagen deposited in the glomeruli and the lesion
score assigned to the mouse.1
Morphometry mapping
Picrosirius red-stained kidney sections from 1-month- (n¼ 10 /
(lesion score G2–4), n¼ 10 þ /þ (lesion score G0), and n¼ 10 þ /
 (lesion score G1–4)) and 2-week-(n¼ 10 / (lesion score G1–3),
n¼ 10 þ /þ (lesion score G0), and n¼ 10 þ / (lesion score G1))
old mice were examined in a blinded fashion to assess individual
glomerulus morphometry lesion distribution and severity within
longitudinal sections (see Supplementary Material). Longitudinal
sections were assessed using four fields of original magnification
 200 that bracketed the renal cortex, from the juxtamedullary
junction to the renal capsule. Each field was divided into
juxtamedullary and cortical halves (zones). Within each zone, we
determined number of glomeruli, number of glomeruli without
collagen deposition (assigned a morphometry score of M¼ 0), with
o25% of glomerular area occupied by collagen (score M¼ 1), with
25–50% of glomerular area occupied by collagen (score M¼ 2),
with 50–75% of glomerular area occupied by collagen (score M¼ 3),
and with 75–100% of glomerular area occupied by collagen (score
M¼ 4). A total score for each animal was then determined by
multiplying the number of glomeruli in each category by their
respective morphometry score, adding the scores, and dividing by
the total number of glomeruli. For example, if 40 glomeruli were
found in the four cortical fields examined and 20 had no collagen
deposition, 10 had morphometry scores of 2, eight had morpho-
metry scores of 3, and two had morphometry scores of 4, the total
score was ((20 0)þ (10 2)þ (8 3)þ (2 4))/40¼ 1.3. Mean
juxtamedullary and cortical glomerular morphometry scores, mean
juxtamedullary and cortical glomerular numbers, mean number of
affected glomeruli, and the percentage of affected glomeruli were
determined for each genotype at 2 weeks and 1 month of age.
Electron microscopy
Kidneys were harvested and fixed in 4% paraformaldehyde, 4%
glutaraldehyde, and 0.1 M cacodylate buffer and tissue processing
carried out as described previously.46 Thin sections were stained
with lead citrate plus uranyl acetate for transmission electron
microscopy.47 Reagents were purchased from Polysciences Inc.
(Warrington, PA).
Albumin to creatinine ratio
To determine whether Col1a2-deficient mice exhibit microalbumin-
uria, urine was collected before killing, stored at 201C and urine
albumin concentration measured using the Albuwell M kit (Exocell,
Philadelphia, PA) following a 1:13 dilution of the urine sample
(Animal Models of Diabetic Complications Consortium, http://
www.amdcc.org/shared/showFile.asp?docTypeID=3&docID=22, 15
September, 2006). Creatinine concentration was analyzed using an
automated Jaffe alkaline picrate assay on a urine sample diluted 1:2.
Quantitative RT-PCR
Snap-frozen kidneys from 1-month- (n¼ 6 / (lesion score
G3–4), n¼ 6 þ /þ (lesion score G0), and n¼ 6 þ / (lesion score
G1–4)), 2-week- (n¼ 7 / (lesion score G1–4), n¼ 6 þ /þ (lesion
score G0), and n¼ 6 þ / (lesion score G1)), and 1-week- (n¼ 6 /
(lesion score G1–2), n¼ 6 þ /þ (lesion score G0), and n¼ 7 þ /
(lesion score G1)) old mice were homogenized in TRIzol reagent
(Invitrogen Corporation, Carlsbad, CA) using a TissueLyser
homogenizer (QIAGEN, Valencia, CA), and total RNA isolated
according to manufacturer’s protocol (Invitrogen Corporation).
Total RNA (5 mg) was reverse transcribed with oligo(dT) primers
according to manufacturer’s protocol (Superscript, Invitrogen
Corporation). PCR primer sequences for Col1a1 and Col1a2 are
found in Table 2. Primer sequences for hypoxanthine–guanine
phosphoribosyltransferase have been previously reported.48 Col1a1
and Col1a2 gene expression was quantified using real-time RT-PCR
(LightCyclers; Roche Diagnostic Corporation, Basel, Switzerland)
in a 20 ml PCR volume that contained cDNA (20 ng/ml), 0.5mM of
forward and reverse primers, 3 mM MgCl2, SYBR
& green, and
QuantiTectTM SYBR& Green PCR Master Mix, which contains dNTP
mix, HotStart Taq DNA Polymerase, reaction buffer I, and SYBR&
green (QIAGEN).49,50 Copy number of the desired genes was deter-
mined through generation of a standard curve using known con-
centrations, 101–106 copies of the PCR-Blunt II-TOPO (Invitrogen
Corporation) plasmid, which contains the amplicon of interest that
was previously cloned. The PCR reactions for Col1a1 and Col1a2
were incubated at 951C for 15 min to activate the polymerase
followed by 40 cycles (15 s denaturation, 941C; 30 s annealing, 601C;
30 s extension, 721C). Fluorescence was monitored at the end of
each extension phase at 801C (5 s) and values were normalized to
hypoxanthine–guanine phosphoribosyltransferase levels.
Table 2 | Primer sequences used for in situ hybridization and quantitative reverse transcriptase-PCR analysis
Primer GI number Sequence Nucleotide segment Amplicon size
ISH and RT-PCR
COL1A1 forward 470673 50-AGC CTG AGT CAG CAG ATT GAG A-30 3676–3698 404 bp
COL1A1 reverse 470673 50-CTT GCA GTG ATA GGT GAT GTT CT-30 4058–4080
ISH
COL1A2 forward 50488 50-CTT CTT GGT GCT CCC GGT ATT CT-30 2693–2715 1365 bp
COL1A2 reverse 50488 50-TTT TGG AGC AGC CAT CGA CTA-30 4038–4058
RT-PCR
COL1A2 forward 50488 50-TGA AGT GGG TCT TCC AGG TCT TTC-30 946–969 235 bp
COL1A2 reverse 50488 50-CAC CCT TGT TAC CGG ATT CTC CTT-30 1158–1181
ISH, in situ hybridization; RT-PCR, reverse transcriptase-polymerase chain reaction.
Kidney International (2007) 71, 985–993 991
AC Brodeur et al.: Type I collagen glomerulopathy o r i g i n a l a r t i c l e
Statistics
Statistical analyses were performed using SAS (SAS Institute Inc.,
Cary, NC). Morphometry data were analyzed as a split plot in space.
The main plot contains effects of gene, age, and the interactions
between genotype and age. The subplot contains effects of side
(cortical versus juxtamedullary) and all possible interactions between
side and the main plot effects. Polynomial orthogonal contrasts were
performed to test for linear and/or quadratic gene dose effect.
Urine data was analyzed as a one-way completely randomized
design analysis of variance. The RT-PCR data was analyzed as a
completely randomized design in which genotype and age were
arranged as a 3/3 factorial (three genotypes, three ages). Owing to
heterogeneous variances among albumin to creatinine ratios and
among copy numbers, log transformations were used to stabilize the
variation. Data presented are the actual mean and standard error but
the differences within genotype and lesion score were analyzed using
the transformed data sets.
Mean differences were ascertained using Fisher’s least significant
difference. All results are presented as mean7s.e. Differences were
considered to be statistically significant at Po0.05.
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